1. Alkaloids: Their relevance in cancer treatment
    Carla Varela et al, 2023, New Insights Into Glioblastoma CrossRef
  2. Molecular dynamics simulation and QM/MM calculation reveal the selectivity mechanism of type I 1/2 kinase inhibitors: the effect of intramolecular H-bonds and conformational restriction for improved selectivity
    Hanxun Wang et al, 2019, Physical Chemistry Chemical Physics CrossRef
  3. Targeting Aberrant Expression of STAT3 and AP-1 Oncogenic Transcription Factors and HPV Oncoproteins in Cervical Cancer by Berberis aquifolium
    Tejveer Singh et al, 2021, Frontiers in Pharmacology CrossRef
  4. Development of 2, 4-diaminoquinazoline derivatives as potent PAK4 inhibitors by the core refinement strategy
    Chenzhou Hao et al, 2017, European Journal of Medicinal Chemistry CrossRef
  5. Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges
    Vivek P. Chavda et al, 2022, Frontiers in Oncology CrossRef
  6. Tinospora species: An overview of their modulating effects on the immune system
    Md. Areeful Haque et al, 2017, Journal of Ethnopharmacology CrossRef
  7. Biological role of the PAK4 signaling pathway: A prospective therapeutic target for multivarious cancers
    Md. Mozibullah et al, 2023, Arabian Journal of Chemistry CrossRef
  8. Unlocking the Goldenseal Reveals the Complexities of Natural Product–Drug Interactions
    Shanukie Embuldeniya et al, 2023, Journal of Pharmacology and Experimental Therapeutics CrossRef
  9. An Acid-Catalyzed Epoxide Ring-Opening/Transesterification Cascade Cyclization to Diastereoselective Syntheses of (±)-β-Noscapine and (±)-β-Hydrastine
    Jihui Li et al, 2019, Organic Letters CrossRef
  10. Studies on asymmetric total synthesis of (−)-β-hydrastine via a chiral epoxide ring-opening cascade cyclization strategy
    Jihui Li et al, 2020, RSC Advances CrossRef
  11. PAK4 in cancer development: Emerging player and therapeutic opportunities
    Yixi Yuan et al, 2022, Cancer Letters CrossRef
  12. [Retracted] Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration
    Yuxin Fu et al, 2021, BioMed Research International CrossRef
  13. Advances in the 1-phenanthryl-tetrahydroisoquinoline series of PAK4 inhibitors: potent agents restrain tumor cell growth and invasion
    Chenzhou Hao et al, 2016, Organic & Biomolecular Chemistry CrossRef
  14. Gene-set Analysis with CGI Information for Differential DNA Methylation Profiling
    Chia-Wei Chang et al, 2016, Scientific Reports CrossRef
  15. Mining Chemodiversity From Biodiversity: Pharmacophylogeny of Ranunculaceae Medicinal Plants
    Da-Cheng Hao, 2019, Ranunculales Medicinal Plants CrossRef
  16. Precise design of highly isoform-selective p21-activated kinase 4 inhibitors: computational insights into the selectivity mechanism through molecular dynamics simulation and binding free energy calculation
    Yuan Su et al, 2020, Journal of Biomolecular Structure and Dynamics CrossRef
  17. Effects of PAK4/LIMK1/Cofilin‐1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells
    Zhi‐Feng Li et al, 2020, Journal of Clinical Laboratory Analysis CrossRef
  18. Enantiodivergent Synthesis of 1-Heteroaryl Tetrahydroisoquinolines Catalyzed by Imine Reductases
    Tingting Liu et al, 2023, Organic Letters CrossRef
  19. Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues
    Sudip Kumar Mandal et al, 2020, Pharmacological Research CrossRef
  20. PDZ and LIM Domain-Encoding Genes: Their Role in Cancer Development
    Xinyuan Jiang et al, 2023, Cancers CrossRef